OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
DOI: 10.1016/s1474-4422(15)00249-5
Authors: Marcelo E Bigal, David W Dodick, Alan M Rapoport, Stephen D Silberstein, Yuju Ma, Ronghua Yang, Pippa S Loupe, Rami Burstein, Lawrence C Newman, Richard B Lipton
Institutions: Teva Pharmaceuticals (United States), Mayo Clinic, Mayo Clinic Hospital, University of California, Los Angeles, Thomas Jefferson University, Beth Israel Deaconess Medical Center, Harvard University, St. Luke's-Roosevelt Hospital Center, Albert Einstein College of Medicine
Language: English

Topic: Migraine and Headache Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed

Funders: Migraine Research Foundation, National Headache Foundation, Teva Pharmaceutical Industries, National Institutes of Health
OpenAlex ID: W2157733244
FWCI: 26.54
Cites: 33
Cited by: 298
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms